DAWN NASDAQ
Day One Biopharmaceuticals, Inc.
1W: +0.3%
1M: +0.8%
3M: +80.2%
YTD: +143.3%
1Y: +189.4%
3Y: +69.9%
$21.53
Last traded 2026-04-24 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$2.2B
52W Range5.635-21.53
Volume0
Avg Volume4,006,348
Beta-1.75
Dividend—
Analyst Ratings
Company Info
CEOJeremy Bender
Employees181
SectorHealthcare
IndustryBiotechnology
IPO Date2021-05-27
Websitedayonebio.com
395 Oyster Point Boulevard
Brisbane, CA 94080
US
Brisbane, CA 94080
US
650 484 0899
About Day One Biopharmaceuticals, Inc.
Operating as a clinical-stage biopharmaceutical entity, Day One Biopharmaceuticals, Inc. is dedicated to discovering and commercializing precise therapeutic options for individuals battling genetically defined cancers. A key asset is DAY101, an orally administered, brain-permeable type II pan-rapidly accelerated fibrosarcoma kinase inhibitor, currently undergoing Phase II clinical trials for young patients experiencing recurrent or worsening low-grade glioma. Additionally, the company is advancing Pimasertib, an oral small molecule designed to inhibit mitogen-activated protein kinase kinases 1 and 2. Established in 2018, Day One Biopharmaceuticals, Inc. maintains its primary operations in South San Francisco, California.
Latest News
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Rating of “Hold” from Analysts
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High – What’s Next?
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Short Interest Down 20.3% in March
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| AI Day1 LLC | U-Tender | 12,929,322 | $21.50 | 2026-04-23 |
| Bender Jeremy | D-Return | 286,000 | $8.99 | 2026-04-23 |
| Bender Jeremy | D-Return | 355,000 | $11.16 | 2026-04-23 |
| Bender Jeremy | D-Return | 222,188 | — | 2026-04-23 |
| VASCONCELLES MICHAEL | D-Return | 346,000 | $6.64 | 2026-04-23 |